Literature DB >> 23283611

Primary amenorrhoea due to a rare cause: epidermolysis bullosa causing haematometra.

Chanchal Singh1, Reva Tripathi, Kabir Sardana, Yedla Manikya Mala.   

Abstract

A 27-year-old woman with junctional epidermolysis bullosa (EB) presented with primary amenorrhoea and massive haematometra. Considering her severe physical handicap and anticipated problems in optimising menstrual hygiene, the patient and her parents opted for hysterectomy which was performed uneventfully. The patient was recovering well postoperatively until the eighth postoperative day when she developed acute dilation of stomach and unfortunately died on day 17.

Entities:  

Mesh:

Year:  2013        PMID: 23283611      PMCID: PMC3603821          DOI: 10.1136/bcr-2012-007542

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

1.  An unusual case of massive gastric distension with catastrophic sequelae.

Authors:  S Lewis; A Holbrook; P Hersch
Journal:  Acta Anaesthesiol Scand       Date:  2005-01       Impact factor: 2.105

Review 2.  Extracutaneous epithelial involvement in inherited epidermolysis bullosa.

Authors:  K A Holbrook
Journal:  Arch Dermatol       Date:  1988-05

3.  Vaginal agglutination and hematometra associated with epidermolysis bullosa.

Authors:  M P Steinkampf; S D Reilly; G E Ackerman
Journal:  Obstet Gynecol       Date:  1987-03       Impact factor: 7.661

4.  Upper airway and external genital involvement in epidermolysis bullosa dystrophica.

Authors:  G D Shackelford; E A Bauer; E R Graviss; W H McAlister
Journal:  Radiology       Date:  1982-05       Impact factor: 11.105

  4 in total
  1 in total

1.  Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline.

Authors:  D T Greenblatt; E Pillay; K Snelson; R Saad; M Torres Pradilla; S Widhiati; A Diem; C Knight; K Thompson; N Azzopardi; M Werkentoft; Z Moore; D Patton; K M Mayre-Chilton; D F Murrell; J E Mellerio
Journal:  Br J Dermatol       Date:  2021-11-25       Impact factor: 11.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.